Decline in influenza infections during the COVID-19 pandemic

One of the few positives to come out of the COVID-19 emergency has been the remarkable decline in influenza virus infections within a few weeks of the emergency declaration. Flutracking Australia’s weekly polling of over 40,000 participants has revealed historically low rates of infection since April 2020. Similar declines in influenza circulation are reported from many other countries in both hemispheres. In the USA positive flu-test results dropped from 20% to 2% and have remained low. Widespread implementation of community mitigation measures, including school closures, social distancing, and mask wearing are seen as the primary drivers in lowering the 2020 incidence of flu.

The results in the graph below generated by the Flutracking initiative for March – December 2020, show the marked decline in influenza infections occurring in Australia for the year compared with 2019 and the 5 year average. .

Flutracking now includes New Zealand, and we would encourage you to sign up to the program.

These findings suggest that such community mitigation measures might be useful adjuncts to influenza vaccination during influenza seasons, particularly for populations at highest risk for developing severe disease or complications. Influenza vaccination for all persons aged remains the best method for influenza prevention and is especially important when SARS-CoV-2 and influenza virus co-circulate.

As we move into 2021, several new corona virus vaccines will become available in Australia and rapid uptake is predicted and recommended.

How can amino acids help?

A good supply of amino acids is important to help the body respond well to a vaccine and of course to help fight infections and recover from colds, flu and ill health. Our immune system needs to make trillions of specialised proteins. Production of these defensive proteins by the body needs large quantities of amino acids, which are the building blocks used to make the proteins. The InnovAAte strategy, using OptimAAte® and ElectrAAte, replenish those amino acids most required to build the immune proteins. This can minimise the breakdown of the body’s own muscle proteins that normally provide the necessary building blocks for the immune proteins. In this way, you can reduce the breakdown of muscle proteins and maintain better well-being throughout your response to the vaccinations.

Shop for OptimAAte® and ElectrAAte® here.

Partner With InnovAAte

At InnovAAte we are always looking for partners to collaborate within research, product development, sales and marketing.